Zhejiang Haisen Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Haisen Pharmaceutical Co., Ltd. was established in 1998 and is a high-tech enterprise specializing in the research and development, production, and sales of chemical raw materials, intermediates, and chemical pharmaceutical preparations. Received honorary titles such as the "Industrial Strong City Contribution Award" and the "Top 100 Taxpayers" in Dongyang City for consecutive years. After years of development, the company has formed a product system mainly composed of digestive system, antipyretic and analgesic, and cardiovascular raw materials, supplemented by antidepressant and antibacterial raw materials, and prepared with antiviral and non-steroidal anti-inflammatory raw materials and preparations under research. The company's products have a wide coverage and can meet the diverse needs of domestic and foreign customers, laying a solid foundation for the company's sustainable development. The company always prioritizes strengthening technological innovation, adheres to the development concept of innovation, and promotes the continuous transformation and upgrading of the company through technological innovation. For a long time, we have adhered to a market-oriented approach and combined industry, academia, and research to form a technology research platform, continuously improving the company's technical level and research and development strength. After years of platform construction, talent reserves, research and development investment, and technology accumulation, the company has a talent team with rich experience and reasonable structure in the research and development of raw materials. The research and development team includes experts who enjoy special allowances from the State Council, as well as early pioneers in individual product fields in China. The company not only focuses on the industrialization of new technologies, but also focuses on market globalization. After years of management accumulation and market development, the company has become one of the main domestic manufacturers of products such as sucralfate and atorvastatin calcium, and has also achieved a high market share in the global market. The company has mature technology and rich experience in quality control, and enjoys a certain level of popularity and recognition in the market. Haisen Pharmaceutical adheres to the core values of "integrity and win-win, safety standards, teamwork, customer first, and continuous innovation", and has established a high standard quality management system, environmental management system, and occupational health and safety management system to safeguard the healthy development of the enterprise. With the development vision of "possessing multiple leading pharmaceutical products, possessing continuous innovative organizational capabilities, and becoming a first-class enterprise with public respect, customer trust, and employee happiness", we strive to fulfill the mission of "committed to continuous research and development, production, and promotion of excellent pharmaceutical products and services, and striving to continuously improve people's quality of life". Based on the company's own business experience and advantages, the company has started to promote the extension of the industrial chain to the research and development, production, and sales of chemical drug formulations, in order to achieve the upgrade to the integrated industrial chain of "intermediates, raw materials, and formulations". |
| Headquarter | Jinhua |
| Establish Date | 2/18/1998 |
| Listed Code | 001367.SZ |
| Listed Date | 4/10/2023 |
| Chairman | Wang Shiyue. |
| CEO | Ailin. |
| Website | www.haisenpharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
